243 related articles for article (PubMed ID: 19372587)
21. STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits.
Chung SS; Giehl N; Wu Y; Vadgama JV
Int J Oncol; 2014 Feb; 44(2):403-11. PubMed ID: 24297508
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional repression of ErbB2 by histone deacetylase inhibitors detected by a genomically integrated ErbB2 promoter-reporting cell screen.
Scott GK; Marden C; Xu F; Kirk L; Benz CC
Mol Cancer Ther; 2002 Apr; 1(6):385-92. PubMed ID: 12477051
[TBL] [Abstract][Full Text] [Related]
23. A novel activating function of c-Src and Stat3 on HGF transcription in mammary carcinoma cells.
Wojcik EJ; Sharifpoor S; Miller NA; Wright TG; Watering R; Tremblay EA; Swan K; Mueller CR; Elliott BE
Oncogene; 2006 May; 25(19):2773-84. PubMed ID: 16407846
[TBL] [Abstract][Full Text] [Related]
24. Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells.
Begon DY; Delacroix L; Vernimmen D; Jackers P; Winkler R
J Biol Chem; 2005 Jul; 280(26):24428-34. PubMed ID: 15870067
[TBL] [Abstract][Full Text] [Related]
25. Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells.
Lv K; Liu L; Wang L; Yu J; Liu X; Cheng Y; Dong M; Teng R; Wu L; Fu P; Deng W; Hu W; Teng L
PLoS One; 2012; 7(7):e40008. PubMed ID: 22808086
[TBL] [Abstract][Full Text] [Related]
26. EZH2 Confers Sensitivity of Breast Cancer Cells to Taxol by Attenuating p21 Expression Epigenetically.
Mu X; Chen M; Xiao B; Yang B; Singh S; Zhang B
DNA Cell Biol; 2019 Jul; 38(7):651-659. PubMed ID: 31140859
[TBL] [Abstract][Full Text] [Related]
27. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity.
Buettner R; Huang M; Gritsko T; Karras J; Enkemann S; Mesa T; Nam S; Yu H; Jove R
Mol Cancer Res; 2007 Aug; 5(8):823-32. PubMed ID: 17699108
[TBL] [Abstract][Full Text] [Related]
28. Distal ERBB2 promoter fragment displays specific transcriptional and nuclear binding activities in ERBB2 overexpressing breast cancer cells.
Delacroix L; Begon D; Chatel G; Jackers P; Winkler R
DNA Cell Biol; 2005 Sep; 24(9):582-94. PubMed ID: 16153159
[TBL] [Abstract][Full Text] [Related]
29. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
Gritsko T; Williams A; Turkson J; Kaneko S; Bowman T; Huang M; Nam S; Eweis I; Diaz N; Sullivan D; Yoder S; Enkemann S; Eschrich S; Lee JH; Beam CA; Cheng J; Minton S; Muro-Cacho CA; Jove R
Clin Cancer Res; 2006 Jan; 12(1):11-9. PubMed ID: 16397018
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21
Tseng TH; Chien MH; Lin WL; Wen YC; Chow JM; Chen CK; Kuo TC; Lee WJ
Environ Toxicol; 2017 Feb; 32(2):434-444. PubMed ID: 26872304
[TBL] [Abstract][Full Text] [Related]
31. Novel role of signal transducer and activator of transcription 3 as a progesterone receptor coactivator in breast cancer.
Proietti CJ; Béguelin W; Flaqué MC; Cayrol F; Rivas MA; Tkach M; Charreau EH; Schillaci R; Elizalde PV
Steroids; 2011 Mar; 76(4):381-92. PubMed ID: 21184768
[TBL] [Abstract][Full Text] [Related]
32. Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp90 in breast cancer cells.
Giordano C; Vizza D; Panza S; Barone I; Bonofiglio D; Lanzino M; Sisci D; De Amicis F; Fuqua SA; Catalano S; Andò S
Mol Oncol; 2013 Jun; 7(3):379-91. PubMed ID: 23228483
[TBL] [Abstract][Full Text] [Related]
33. Low inducible expression of p21Cip1 confers resistance to paclitaxel in BRAF mutant melanoma cells with acquired resistance to BRAF inhibitor.
Jang GH; Kim NY; Lee M
Mol Cell Biochem; 2015 Aug; 406(1-2):53-62. PubMed ID: 25912549
[TBL] [Abstract][Full Text] [Related]
34. Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells.
Trost TM; Lausch EU; Fees SA; Schmitt S; Enklaar T; Reutzel D; Brixel LR; Schmidtke P; Maringer M; Schiffer IB; Heimerdinger CK; Hengstler JG; Fritz G; Bockamp EO; Prawitt D; Zabel BU; Spangenberg C
Cancer Res; 2005 Feb; 65(3):840-9. PubMed ID: 15705882
[TBL] [Abstract][Full Text] [Related]
35. Estrogen-related receptor alpha1 transcriptional activities are regulated in part via the ErbB2/HER2 signaling pathway.
Ariazi EA; Kraus RJ; Farrell ML; Jordan VC; Mertz JE
Mol Cancer Res; 2007 Jan; 5(1):71-85. PubMed ID: 17259347
[TBL] [Abstract][Full Text] [Related]
36. Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p53 and Sp1.
Choi WI; Jeon BN; Yun CO; Kim PH; Kim SE; Choi KY; Kim SH; Hur MW
J Biol Chem; 2009 May; 284(19):12633-44. PubMed ID: 19244234
[TBL] [Abstract][Full Text] [Related]
37. Secreted GRP78 activates EGFR-SRC-STAT3 signaling and confers the resistance to sorafeinib in HCC cells.
Li R; Yanjiao G; Wubin H; Yue W; Jianhua H; Huachuan Z; Rongjian S; Zhidong L
Oncotarget; 2017 Mar; 8(12):19354-19364. PubMed ID: 28423613
[TBL] [Abstract][Full Text] [Related]
38. Estrogen regulated expression of the p21 Waf1/Cip1 gene in estrogen receptor positive human breast cancer cells.
Mandal S; Davie JR
J Cell Physiol; 2010 Jul; 224(1):28-32. PubMed ID: 20301197
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of ErbB2-mediated paclitaxel resistance and trastuzumab-mediated paclitaxel sensitization in ErbB2-overexpressing breast cancers.
Yu D
Semin Oncol; 2001 Oct; 28(5 Suppl 16):12-7. PubMed ID: 11706391
[TBL] [Abstract][Full Text] [Related]
40. c-Src associates with ErbB2 through an interaction between catalytic domains and confers enhanced transforming potential.
Marcotte R; Zhou L; Kim H; Roskelly CD; Muller WJ
Mol Cell Biol; 2009 Nov; 29(21):5858-71. PubMed ID: 19704002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
